X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3700) 3700
Publication (470) 470
Book Review (86) 86
Book Chapter (38) 38
Conference Proceeding (9) 9
Book / eBook (7) 7
Dissertation (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2640) 2640
index medicus (2346) 2346
oncology (1876) 1876
cancer (1528) 1528
female (965) 965
metastasis (858) 858
animals (837) 837
metastatic colorectal-cancer (837) 837
chemotherapy (824) 824
male (822) 822
middle aged (692) 692
metastatic breast-cancer (658) 658
aged (621) 621
tumors (615) 615
care and treatment (598) 598
metastatic melanoma (551) 551
neoplasms - drug therapy (535) 535
research (520) 520
cell lung-cancer (507) 507
pancreatic cancer (498) 498
adult (483) 483
pharmacology & pharmacy (482) 482
immunotherapy (429) 429
antineoplastic agents - therapeutic use (407) 407
treatment outcome (398) 398
survival (394) 394
medicine & public health (390) 390
health aspects (386) 386
analysis (375) 375
prognosis (365) 365
melanoma (360) 360
cancer therapies (342) 342
antineoplastic combined chemotherapy protocols - therapeutic use (339) 339
breast-cancer (339) 339
mice (339) 339
pancreatic-cancer (337) 337
review (329) 329
article (325) 325
cell biology (315) 315
breast cancer (302) 302
phase-ii trial (298) 298
cell line, tumor (297) 297
phase-iii trial (296) 296
neoplasm metastasis (291) 291
gemcitabine (288) 288
clinical trials (281) 281
therapy (277) 277
colorectal cancer (275) 275
neoplasms - pathology (259) 259
medicine, research & experimental (258) 258
neoplasms - therapy (256) 256
metastases (255) 255
cancer research (253) 253
immunology (251) 251
drug therapy (248) 248
development and progression (246) 246
aged, 80 and over (245) 245
expression (242) 242
patients (240) 240
surgery (239) 239
angiogenesis (234) 234
mutation (232) 232
lung-cancer (231) 231
deoxycytidine - analogs & derivatives (227) 227
carcinoma (225) 225
endothelial growth-factor (223) 223
pancreatic neoplasms - pathology (222) 222
clinical trials as topic (220) 220
genetic aspects (219) 219
pancreatic neoplasms - drug therapy (219) 219
antineoplastic agents - pharmacology (217) 217
bevacizumab (216) 216
apoptosis (212) 212
proteins (212) 212
biochemistry & molecular biology (208) 208
growth-factor receptor (208) 208
adenocarcinoma (207) 207
medical research (207) 207
antineoplastic agents (206) 206
colorectal-cancer (206) 206
medicine (200) 200
biomarkers (196) 196
antimitotic agents (189) 189
neoplasms - immunology (188) 188
medical prognosis (187) 187
pathology (186) 186
neoplasms - genetics (178) 178
gene expression (176) 176
phase-ii (176) 176
antibodies, monoclonal - therapeutic use (175) 175
solid tumors (173) 173
1st-line treatment (172) 172
hematology, oncology and palliative medicine (172) 172
prostate-cancer (172) 172
neoplasms - metabolism (170) 170
antineoplastic combined chemotherapy protocols - adverse effects (166) 166
diagnosis (165) 165
studies (161) 161
disease-free survival (159) 159
vascular endothelial growth factor (159) 159
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3671) 3671
Japanese (43) 43
French (14) 14
German (12) 12
Korean (4) 4
Polish (2) 2
Turkish (2) 2
Chinese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 4712 - 9
The recent past has seen impressive progress in the treatment of various malignancies using immunotherapy. One of the most promising approaches involves immune... 
TRIAL | NANOPARTICLES | MULTICENTER | THERAPY | MULTIDISCIPLINARY SCIENCES | DOXORUBICIN | METASTATIC UROTHELIAL CARCINOMA | ATEZOLIZUMAB | GEMCITABINE | Nuclear magnetic resonance--NMR | Immune checkpoint | Gemcitabine | Magnetic resonance imaging | RNA-mediated interference | Pancreatic cancer | Immunotherapy | PD-L1 protein | siRNA | Cancer therapies | Survival | Tumors
Journal Article
Journal Article
Cytotechnology, ISSN 0920-9069, 10/2019, Volume 71, Issue 5, pp. 989 - 1002
Cancer metastasis is believed to happen through active intravasation but there might be also another way to metastasize. According to passive shedding... 
Biomedicine, general | Biochemistry, general | Biotechnology | Chemistry | passive sheding mechanism | In vitro metastatic selection | Panc-02 | Pancreatic cancer metastasis | Cancer model | Metastasis | Pancreatic cancer | Analysis | Cells | Original
Journal Article
Journal Article
Journal Article
ONCOTARGETS AND THERAPY, ISSN 1178-6930, 2019, Volume 12, pp. 3077 - 3085
Purpose: Metastatic pancreatic adenocarcinoma has a very poor prognosis. Although irinotecan, oxaliplatin and leucovorin-modulated fluorouracil (FOLFIRINOX)... 
SURVIVAL | FOLFIRINOX | EFFICACY | SAFETY | ADENOCARCINOMA | locally advanced pancreatic cancer | TUMOR RESPONSE | COMBINATION | chemotherapy | PHASE-III TRIAL | ONCOLOGY | TREATMENT PATTERNS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | PACLITAXEL PLUS GEMCITABINE | metastatic pancreatic cancer | Pancreatic cancer | Medical prognosis | Metastasis | Metastatic pancreatic cancer
Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 06/2015, Volume 16, Issue 3, pp. 221 - 229
Background Erlotinib has been reported as being associated with a high incidence of skin toxicities such as acneiform rash, paronychia, and xerosis. Objective... 
CELL LUNG-CANCER | EGFR INHIBITORS | RASH | CLINICAL-TRIALS GROUP | PHASE-III | ACNE | RANDOMIZED-TRIAL | JAPANESE PATIENTS | RECEPTORS | METASTATIC COLORECTAL-CANCER | DERMATOLOGY | Index Medicus
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 6/2013, Volume 71, Issue 6, pp. 1485 - 1491
Platinum compounds or bevacizumab, in combination with gemcitabine, achieved good response rates in early studies in advanced pancreatic cancer. This prompted... 
Medicine & Public Health | Pancreatic cancer | Chemoradiation | Oncology | Cancer Research | Pharmacology/Toxicology | Locally advanced | Bevacizumab | PLUS GEMCITABINE | ADENOCARCINOMA | FLUOROURACIL | COMBINATION | METASTATIC COLORECTAL-CANCER | PHASE-III TRIAL | BREAST-CANCER | THERAPY | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | PHARMACOLOGY & PHARMACY | COOPERATIVE-ONCOLOGY-GROUP | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Radiotherapy - adverse effects | Pancreatic Neoplasms - drug therapy | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Female | Adenocarcinoma - radiotherapy | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Pancreatectomy | Pancreatic Neoplasms - radiotherapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Pilot Projects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Deoxycytidine - analogs & derivatives | Adenocarcinoma - surgery | Cancer patients | Care and treatment | Chemotherapy | Radiotherapy | Cancer | Fluorouracil | Index Medicus | 5-Fluorouracil
Journal Article
memo - Magazine of European Medical Oncology, ISSN 1865-5041, 2/2014, Volume 7, Issue 1, pp. 39 - 42
The first biologically interactive albumin-bound paclitaxel in a nanometer particle is described in a patient with metastatic pancreatic cancer. The aim of... 
Case report | Chemotherapy | Medicine & Public Health | Clinical benefit | Oncology | Medicine/Public Health, general | Nab-paclitaxel | Metastatic pancreatic cancer | Antimitotic agents | Metastasis | Antineoplastic agents | Pancreatic cancer | Cancer
Journal Article
Gastroenterology Clinics of North America, ISSN 0889-8553, 09/2016, Volume 45, Issue 3, pp. 429 - 445
Journal Article
WORLD JOURNAL OF SURGICAL ONCOLOGY, ISSN 1477-7819, 04/2019, Volume 17, Issue 1, p. 76
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2017, Volume 23, Issue 12, pp. 2942 - 2950
Journal Article